Intraindividual Interleukin-6 Variations on the Cardiovascular Prognosis of Patients with Chronic Renal Disease

REFERENCES

• Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658.
   PubMed Web of Science ®Google Scholar
• Qureshi AR, Alvestrand A, Divino-Filho JC, . Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients J Am Soc Nephrol. 2002;13(Suppl. 1):S28–S36.
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: A hypothesis proposal. Clin J Am Soc Nephrol. 2009;4:S49–S55.
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Stenvinkel P. Inflammation in endstage renal disease—What have we learned in 10 years? Semin Dial. 2010;23:498–509.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in hemodialysis patients. Nephrol Dial Transplant. 2004;19:1507–1519.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidants and antioxidants. Exp Physiol. 1997; 82(2):291–295.
   PubMed Web of Science ®Google Scholar
• Dounousi E, Papavasiliou E, Makedou A, . Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis. 2006;48(5):752–760.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Diczfalusy U, Lindholm B, Heimbuürger O. Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy. Nephrol Dial Transplant. 2004;19(4):972–976.
   PubMed Web of Science ®Google Scholar
• Quiroga B, Marin C, Goicoechea M, Reque J, Luño J. Inflammatory biomarkers in chronic kidney disease: A review. Recent Pat Biomark. 2012;2:131–138.
   Google Scholar
• Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int. 2005;67:2330–2337.
   PubMed Web of Science ®Google Scholar
• Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by multivariate modeling. J Am Soc Nephrol. 2005;16(Suppl. 1):S83–S88.
   Google Scholar
• Zacho J, Tybiaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008;359:1897–1908.
   PubMed Web of Science ®Google Scholar
• Zhang L, Khao WH, Berthier-Schaad Y, . C-reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort. Am J Kidney Dis. 2007;49:118–126.
   PubMedGoogle Scholar
• Liu Y, Berthier-Schaad Y, Fallin MD, . IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol. 2006;17:863–870.
   PubMed Web of Science ®Google Scholar
• Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6 174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J. 2001;22:2243–2252.
   PubMed Web of Science ®Google Scholar
• Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275:18138–18144.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Tripepi G, Mallamaci F. Dissecting inflammation in ESRD: Do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol. 2006;17:S169–S173.
   Google Scholar
• Barreto DV, Barreto FC, Liabeuf S, . Plasma Intereukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int. 2010;77:550–556.
   PubMed Web of Science ®Google Scholar
• Nascimento MM, Pecoits-Filho R, Qureshi AR, . The prognostic impact of fluctuating levels of C-reactive protein in Brazilian hemodialysis patients: A prospective study. Nephrol Dial Transplant. 2004;19:2803–2809.
   PubMed Web of Science ®Google Scholar
• Den Elzen WP, van Manen JG, Boeschoten EW, Krediet RT, Dekker FW. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. Nephrol Dial Transplant. 2006;21:1588–1595.
   PubMedGoogle Scholar
• Goicoechea M, de Vinuesa SG, Lahera V, . Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(Suppl. 3):S231–S235.
   Google Scholar
• de Vinuesa SG, Goicoechea M, Kanter J, . Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: Effects of angiotensin II blockade. J Am Soc Nephrol. 2006;17(12 Suppl. 3):S206–S212.
   Google Scholar
• Meuwese CL, Halbesma N, Stenvinkel P, . Variations in C-reactive protein during a single hemodialysis session do not associate with mortality. Nephrol Dial Transplant. 2010;25: 3717–3723.
   PubMed Web of Science ®Google Scholar
• Ates K, Ates A, Ekmekci Y, Nergizoglu G. The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients. Perit Dial Int. 2005;25:256–268.
   PubMedGoogle Scholar
• Platz EA, Sutcliffe S, De Marzo AM, . Intra-individual variation in serum C-reactive protein over 4 years: An implication for epidemiologic studies. Cancer Causes Control. 2010;21: 847–851.
   PubMed Web of Science ®Google Scholar
• Rao M, Guo D, Perianavagam MC, . Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2005;45:324–333.
   PubMed Web of Science ®Google Scholar
• Panichi V, Maggiore U, Taccola D, . Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in hemodialysis patients. Nephrol Dial Transplant. 2004;19:1154–1160.
   PubMed Web of Science ®Google Scholar
• Hasuike Y, Nonoguchi H, Ito K, . Interleukin-6 is a predictor of mortality in stable hemodialysis patients. Am J Nephrol. 2009;30:389–398.
   PubMed Web of Science ®Google Scholar
• Racki S, Zaputovic L, Mavric Z, Vujicić B, Dvornik S. C-reactive protein is a strong predictor of mortality in hemodialysis patients. Ren Fail. 2006;28:427–433.
   PubMed Web of Science ®Google Scholar
• Menon V, Greene T, Wang X, . C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005;68:766–772.
   PubMed Web of Science ®Google Scholar
• Oberg BP, McMenamin E, Lucas FL, . Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65: 1009–1016.
   PubMed Web of Science ®Google Scholar
• Yilmaz MI, Stenvinkel P, Sonmez A, . Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Nephrol Dial Transplant. 2011;26: 3537–3543.
   PubMed Web of Science ®Google Scholar
• Koukkunen H, Penttila K, Kemppainen A, . C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor alpha in the prognostic classification of unstable angina pectoris. Ann Med. 2001;33:37–47.
   PubMed Web of Science ®Google Scholar
• Schieffer B, Schieffer E, Hilfiker-kleiner D, . Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability. Circulation. 2000;101:1372–1378.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Stampfer MJ, . Plasma concentration of interlukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767–1772.
   PubMed Web of Science ®Google Scholar
• Torre-Amione G, Kapadia S, Benedict C, . Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction a report from the Studies of Left Ventricular Disfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201–1206.
   PubMed Web of Science ®Google Scholar
• Dekker FW, de Mutsert R, van DijK PC, Zoccali C, Jager KJ. Survival analysis: Time-dependent effects and time-varying risk factors. Kidney Int. 2008;74:994–997.
   PubMed Web of Science ®Google Scholar
• Bazeley J, Bieber B, Li Y, . C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:2452–2461.
   PubMed Web of Science ®Google Scholar
• van Tellingen A, Grooteman MP, Schoorl M, . Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients. Kidney Int. 2002;62:632–638.
   PubMedGoogle Scholar
• Meuwese CL, Stenvinkel P, Dekker FW, Carrero JJ. Monitoring of inflammation in patients on dialysis: Forewarned is ofrearmed. Nat Rev Nephrol. 2011;7:166–176.
   PubMed Web of Science ®Google Scholar
• Snaedal S, Heimburger O, Qureshi AR, . Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: Implications for patient survival. Am J Kidney Dis. 2009;53:1024–1033.
   PubMed Web of Science ®Google Scholar
• Bogaty P, Brophy JM, Boyer L, . Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch Intern Med. 2005;165:221–226.
   PubMed Web of Science ®Google Scholar
• Nasermoaddeli A, Sekine M, Kagamimori S. Intra-individual variability of high-sensitivity C-reactive protein: Age-related variations overtime in Japanese subjects. Circ J. 2006;70: 559–563.
   PubMedGoogle Scholar
• Picotte M, Campbell CG, Thorland WG. Day-to-day variation in plasma interleukin-6 concentrations in older adults. Cytokine. 2009;47:162–165.
   PubMed Web of Science ®Google Scholar
• Kim BS, Jeon DS, Shin MJ, . Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis. Am J Nephrol. 2005;25:189–195.
   PubMed Web of Science ®Google Scholar
• Meuwese CJ, Snaedal S, Halbesma N, . Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in hemodialysis patient. Nephrol Dial Transplant. 2011;26: 1313–1318.
   PubMed Web of Science ®Google Scholar